Seelos Therapeutics Inc (SEELQ)

[Shazam619]

Femprox is probably "dead" for 2014 but could come back to life in 2015. We don't know how much interest there is in Femprox but what we do know is that there isn't the kind of interest Pascoe wants until there's some clarity from the FDA on FSAID.

I think dead is being interpreted as never coming back and that's not the case with Femprox. If we the FDA rejected it and Pascoe said they were going to stop pursuing it then it would be dead.

If you were running this company all of the management would have been hired and fired within a month. That's not a good way to acquire or retain talent. Pascoe's doing a good job but has told us too much. Most companies don't release this much information. Then they don't have to back track when there's a problem.

In my opinion Femprox should never have taken a front seat over Vitaros. The product that generates the most money this year should be our focus and that's going to be Vitaros for a couple years. Then RayVa, and finally Femprox. Hopefully there will be some good surprises added on to that in 2015.

With all these launches pending, I find myself wondering if we'll have some news every Monday. :)